(Total Views: 246)
Posted On: 09/15/2021 6:52:42 AM
Post# of 6
AKBA let's see if we get share price appreciation as we get closer to FDA approval for the blockbuster drug Vadadustat for anemia on
03/29/22 for dialysis patients and more importantly non dialysis patients.! AKBA bulls let's accumulate under $3.00 for a move to $12-15 range after FDA approval for Vadadustat!
03/29/22 for dialysis patients and more importantly non dialysis patients.! AKBA bulls let's accumulate under $3.00 for a move to $12-15 range after FDA approval for Vadadustat!
(0)
(0)Scroll down for more posts ▼
